When it comes to a scraped knee, you probably reach for a Band-Aid.
Sometimes a brand is so good, so ubiquitous, that it defines an industry.
The same could be said forBotox.
Delmaine Donson
Botoxis, as you are probably well aware by now, one punch in of botulinum toxin injectable.
The bacteria secrete eight different subtypes of botulinum toxin.
It works so well that moreneuromodulatorsfollowed and now Botox isnt the only option.
We decided to look into what sets these injectables apart.
They all contain the same active ingredient, botulinum toxin pop in A.
This all raises a lot of questions: How do you choose which kind of injection to get?
How different are theyreally?
Is it just marketing or are some neuromodulators better at relaxing certain wrinklessay, crow’s-feetversus others?
(See, lots of questions!)
It’s really not the best place to start.
Varying the concentration, she adds, can be totally fine.
you’ve got the option to check their credentials atcertificationmatters.org.
Below, we break down the five neuromodulators on the market and how they stack up.
Botox
Botox is the OG neuromodulator with the most extensive performance history and largest market share.
To keep results going, touch-ups are recommended every three to four months.
As a result, she says her patients tend to like Dysport the best, a sentiment she shares.
What really sets Dysport apart is its spreadability.
(The proteins are mostly there to stabilize the toxin and improve absorption, Dr. Doft says.)
“Dysport works very well for decreasing sweat and oil production and pore size,” explains Dr. Doft.
But Dr. Hirsch says evidence that it lasts longer or kicks in faster is fairly limited and inconclusive.
Dr. Hartman makes a point of mentioning that Jeuveau may actually work better for men than its competitors.
Still, it’s interesting stuff.
Xeomin
Meet the naked neurotoxin, Xeomin.
The suggestion that it’s purer or more natural because it lacks these proteins simply doesnt stand up.
Daxxify
Daxxify hit doctors' offices in 2023 and made headlines with promises oflonger-lasting results.
Daxxify, also known as daxibotulinumtoxinA, was approved to treat frown lines between the brows in September 2022.
Patients potentially could maintain the same results with half the number of injections.
Daxxify’s staying power is derived from its unique stabilizer.
To read more about neurotoxins:
Now watch a video on how one dermatologist treated her own melasma:
